<?xml version="1.0" encoding="UTF-8"?>
<table xmlns="http://www.w3.org/1999/xhtml">
 <caption class="caption">
  <label class="label">Table 34</label>
  <p class="p" xmlns="">Clinical trials on patients with generalized anxiety disorder.</p>
 </caption>
 <thead class="thead">
  <tr class="tr" xmlns="">
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Design</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Treatment</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Patients (n)</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Key Effects</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">References</th>
  </tr>
 </thead>
 <tbody class="tbody">
  <tr class="tr" xmlns="">
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <bold class="bold">Clinical trial</bold>
    <break class="break"/>randomized 
    <break class="break"/>double-blind 
    <break class="break"/>placebo-controlled 
   </td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Kava Extract 
    <break class="break"/>(3 X 100 mg)/day 
    <break class="break"/>
    <bold class="bold">Duration:</bold> 4 Weeks 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <italic class="italic">n</italic> = 58 
   </td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">-Hamilton-Anxiety-Scale (HAMA) Score significantly reduced in drug receiving group compared to placebo group. 
    <break class="break"/>-No adverse effects. 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B367-molecules-24-01364" ref-type="bibr" class="xref">367</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <bold class="bold">Clinical trial</bold>
    <break class="break"/>randomized 
    <break class="break"/>double-blind 
    <break class="break"/>placebo-controlled 
   </td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Kava Extract 
    <break class="break"/>(3 X 110mg)/day 
    <break class="break"/>
    <bold class="bold">Duration:</bold> 25 Weeks 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <italic class="italic">n</italic> = 101 
   </td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">-Significant superiority of kava extract in Hamilton-Anxiety-Scale (HAMA) Score over the placebo starting from week 8. 
    <break class="break"/>-Rare and evenly distributed adverse effects. 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B368-molecules-24-01364" ref-type="bibr" class="xref">368</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <bold class="bold">Clinical trial</bold>
    <break class="break"/>randomized 
    <break class="break"/>double-blind 
    <break class="break"/>placebo-controlled 
   </td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Kava Extract 
    <break class="break"/>(280 mg)/day 
    <break class="break"/>
    <bold class="bold">Duration:</bold> 4 Weeks 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <italic class="italic">n</italic> = 13 
   </td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">-Significantly improved baroreflex control of heart rare following treatment with placebo. 
    <break class="break"/>-No effect on respiratory sinus arrhythmia. 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B407-molecules-24-01364" ref-type="bibr" class="xref">407</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <bold class="bold">Clinical trial</bold>
    <break class="break"/>randomized 
    <break class="break"/>open study 
   </td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Kava Extract 
    <break class="break"/>(100 and 200 mg)/day 
    <break class="break"/>
    <bold class="bold">Duration:</bold> 3 Months 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <italic class="italic">n</italic> = 80 
   </td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">-In kava treatment groups anxiety climacteric score declined at 1.and 3. Months. 
    <break class="break"/>-Depression reduced at month 3. 
    <break class="break"/>-In control group no significant result. 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B413-molecules-24-01364" ref-type="bibr" class="xref">413</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <bold class="bold">Clinical trial</bold>
    <break class="break"/>double-blind 
    <break class="break"/>crossover trial 
    <break class="break"/>placebo-controlled 
   </td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Kava Extract 
    <break class="break"/>5 tablets/day 
    <break class="break"/>Containing 3.2 g extract (delivering 50 mg kavalactones) 
    <break class="break"/>
    <bold class="bold">Duration:</bold> 1 month 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <italic class="italic">n</italic> = 60 
   </td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">-Kava resulted in 11.4 points reduction on HAMA Score over placebo. 
    <break class="break"/>-Antidepressant effect. 
    <break class="break"/>-No serious adverse effect. 
    <break class="break"/>-No clinical hepatotoxicity. 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B416-molecules-24-01364" ref-type="bibr" class="xref">416</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <bold class="bold">Clinical trial</bold>
    <break class="break"/>randomized 
    <break class="break"/>double-blind 
    <break class="break"/>placebo-controlled 
   </td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Kava Extract1 or 2 tablet/day 
    <break class="break"/>(120 or 240 mg) kavalactone 
    <break class="break"/>
    <bold class="bold">Duration:</bold> 6 Weeks 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <italic class="italic">n</italic> = 75 
   </td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">-Significant increase in femaleâ€™s sexual drive in Kava group compared to placebo (assessed by ASEX). 
    <break class="break"/>-Significant reduction of anxiety in Kava group compared to placebo (assessed by HAMA). 
    <break class="break"/>-No significant differences across groups for liver function test. 
    <break class="break"/>-No differences in withdraw or addiction. 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B417-molecules-24-01364" ref-type="bibr" class="xref">417</xref>, 
    <xref rid="B418-molecules-24-01364" ref-type="bibr" class="xref">418</xref>] 
   </td>
  </tr>
 </tbody>
</table>
